1. Home
  2. Analysis
  3. Vytorin
  4. Xopenex-hfa

Vytorin and Xopenex hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vytorin and Xopenex hfa. Common interactions include chronic kidney disease among females and coma among males.

The phase IV clinical study analyzes what interactions people who take Vytorin and Xopenex hfa have. It is created by eHealthMe based on reports of 10 people who take Vytorin and Xopenex hfa from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

10 people who take Vytorin and Xopenex hfa together, and have interactions are studied.

What is Vytorin?

Vytorin has active ingredients of ezetimibe; simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 19,816 Vytorin users for its effectiveness, alternative drugs and more.

What is Xopenex hfa?

Xopenex hfa has active ingredients of levalbuterol tartrate. It is often used in asthma. eHealthMe is studying from 2,137 Xopenex hfa users for its effectiveness, alternative drugs and more.

Number of Vytorin and Xopenex hfa reports submitted per year:

Vytorin and Xopenex hfa drug interactions.

Common Vytorin and Xopenex Hfa drug interactions by gender *:

female:

  1. Chronic kidney disease
  2. Renal failure
  3. Cough
  4. Decreased activity
  5. Dyspnoea
  6. Eye pain
  7. Injection site haematoma
  8. Injection site mass
  9. Insomnia
  10. International normalised ratio decreased

male:

  1. Coma
  2. Haemorrhagic stroke
  3. Renal impairment
  4. Vomiting
  5. Respiratory failure
  6. Anaphylactic reaction
  7. Fatigue
  8. Gastrointestinal pain
  9. Headache
  10. Hypersensitivity

Common Vytorin and Xopenex Hfa drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Renal failure
  3. Anaphylactic reaction
  4. Fatigue
  5. Gastrointestinal pain
  6. Headache
  7. Hypersensitivity
  8. Nausea
  9. Vomiting

60+:

  1. Coma
  2. Haemorrhagic stroke
  3. Insomnia
  4. International normalised ratio decreased
  5. International normalised ratio increased
  6. Joint injury
  7. Pneumonia pseudomonal
  8. Productive cough
  9. Pulmonary thrombosis
  10. Somnambulism

Common conditions people have *:

  1. High Blood Pressure: 4 people, 40.00%
  2. Diabetes: 4 people, 40.00%
  3. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 20.00%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 20.00%
  5. Atrial Thrombosis (blood clot that develops in an artery): 2 people, 20.00%
  6. Cardiac Failure Congestive: 2 people, 20.00%
  7. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 20.00%
  8. Constipation: 2 people, 20.00%
  9. Fluid Retention (an abnormal accumulation of fluid in the blood): 2 people, 20.00%
  10. Fungal Infection: 2 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Vytorin and Xopenex hfa?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Vytorin and Xopenex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vytorin side effects:

Browse all side effects of Vytorin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xopenex hfa side effects:

Browse all side effects of Xopenex hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Vytorin interactions:

Browse all interactions between Vytorin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Xopenex hfa interactions:

Browse all interactions between Xopenex hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ezetimibe; simvastatin and levalbuterol tartrate (the active ingredients of Vytorin and Xopenex hfa, respectively), and Vytorin and Xopenex hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Vytorin and Xopenex hfa.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.